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Animals given repeated intermittent injections 
of amphetamine (AMP) develop a hypersensitivity 
to the motor stimulant effects of AMP that per- 
sists for months following the cessation of drug 
treatment. This behavioral sensitization to AMP 
may be due to AMP's  action as a stressor, because 
prior exposure to stress also produces an enduring 
hypersensitivity to the motor  stimulant effects of 
AMP (Antelman and Chiodo, 1983). If this hy- 
pothesis is correct, sensitization to AMP and stress 
should be associated with similar long-lasting 
changes in the nervous system. We previously 
reported that the behavioral sensitization pro- 
duced by AMP is accompanied by an enduring 
enhancement in AMP-st imulated endogenous 
dopamine (DA) release from striatal tissue in vitro 
(Robinson and Becker, 1982). The purpose of the 
present experiment was to determine if prior stress 
also produces an enduring enhancement in AMP- 
stimulated striatal DA release. 
Ovariectomized (OVX) female rats were used 
for two reasons: (1) female rats show more robust 
sensitization than males; and (2) OVX eliminates 
the fluctuations in striatal DA release associated 
with the estrous cycle (Robinson and Becker, in 
press). Two weeks after OVX the rats received an 
i.p. injection of either 0.9% saline (SAL; 1 ml /kg )  
of 3.0 m g / k g  d-AMP sulfate (3.0 m g / m l )  once 
daily for 5 days. Because saline injections and the 
associated handling produce a typical 'stress re- 
sponse' (Sakellaris and Vernikos-Danellis, 1975) it 
was predicted that this alone would result in an 
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enduring enhancement in AMP-stimulated DA re- 
lease, relative to non-handled control animals. 
Therefore, a third group of rats were left undis- 
turbed during this time (non-handled controls; 
NH).  Ten days after the last injection all rats were 
decapitated, the striatum dissected rapidly in ice- 
cold medium and then placed into superfusion 
chambers. Medium continuously flowed through 
the chambers at a rate of 100/~l /min,  and 5 min 
effluent samples were later assayed for DA. The 
superfusion method is described in detail by Becker 
et al. (1984). Following a 65 min equilibration 
period and collection of three baseline samples, 10 
/~M d-AMP was added to the medium for 2.5 min, 
and an additional 5 samples collected. 
The addition of AMP to the medium stimu- 
lated endogenous DA release from all chambers. 
However, as illustrated in fig. 1, there was a 
significant effect of pretreatment condition on 
AMP-stimulated striatal DA release (F(5,4), P = 
0.011). Stiatal tissue obtained from AMP-pre- 
treated rats released significantly more DA in 
response to AMP stimulation than tissue obtained 
from either SAL or N H  rats. Furthermore, striatai 
tissue obtained from SAL rats released more DA 
than tissue obtained from N H  rats (fig. 1). The 
three groups did not differ in basal levels of DA 
efflux prior to AMP stimulation, but it should be 
noted that basal DA efflux is not calcium- or 
temperature-dependent (Becker et al., 1984). 
In summary, it was found that repeated inter- 
mittent exposure to AMP produces an enduring 
enhancement in AMP-stimulated DA release from 
striatal tissue in vitro, as previously reported 
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Fig. 1. Mean (+ S.E.M.) amphetamine (AMP)-stimulated en- 
dogenous DA release from striatal tissue fragments (approxi- 
mately 1 mm 3) obtained from rats that 10 days previously 
received the last of 5 daily injections of saline (SAL; n = 11) or 
3.0 mg/kg of AMP (n = 12), or were non-handled (NH; n = 5). 
The means represent the average release rate in pg DA/mg 
tissue per rain over four 5 rain intervals following the addition 
of 10 /~M AMP to the superfusion medium for 2.5 rain. The 
average basal level of DA efflux was 13.4 + 6.2 pg/mg per rain. 
Statistical analyses were conducted on the log transformed 
data, and because the effects of SAL and AMP were predicted 
consisted of planned one-tailed t-tests. * NH differs from SAL 
(t=1.76, P=0.049), and AMP (t=2.9, P=0.005); ~SAL 
differs from AMP (t = 1.86, P = 0.037). 
( R o b i n s o n  and  Becker ,  1982; R o b i n s o n  and  
Becker ,  in press).  M o r e  i m p o r t a n t l y ,  this is the  
first  r epo r t  tha t  r e p e a t e d  i n t e r m i t t e n t  e x p o s u r e  to 
the  stress o f  sa l ine  in jec t ions  ( and  assoc ia ted  han -  
d l ing)  also p r o d u c e s  an  e n d u r i n g  (at  least  10 days)  
e n h a n c e m e n t  in A M P - s t i m u l a t e d  s t r ia ta l  D A  re- 
lease.  W h e t h e r  the  g rea te r  ef fec t  of  A M P  o v e r  
S A L  p r e t r e a t m e n t  is due  to s o m e  u n i q u e  p r o p e r t y  
o f  A M P ,  o r  because  this is j u s t  a m o r e  p o t e n t  
s t ressor  t han  S A L  is n o t  k n o w n .  H o w e v e r ,  pre-  
l i m i n a r y  d a t a  f r o m  this lab  suggest  that  r epea t ed  
i m m o b i l i z a t i o n  stress is no t  m o r e  e f f icac ious  than  
S A L  in e n h a n c i n g  D A  release.  Never the less ,  it is 
l ikely  that  an e n d u r i n g  e n h a n c e m e n t  in A M P -  
s t i m u l a t e d  s t r ia ta l  D A  release  is at least  pa r t i a l ly  
r e spons ib l e  for  the  e n d u r i n g  hyper sens i t iv i ty  to 
the  m o t o r - s t i m u l a n t  ef fects  o f  A M P  seen in 
a n i m a l s  p r ev ious ly  exposed  to stress ( A n t e l m a n  
a n d  Ch iodo ,  1983). F u r t h e r m o r e ,  these da t a  raise 
the  poss ib i l i ty  that  e n d u r i n g  changes  in b ra in  D A  
sys tems p r o d u c e d  by r epea t ed  exposu re  to stress 
c o n t r i b u t e  to the d e v e l o p m e n t  of  s t ress-prec ip i -  
t a ted  p s y c h o p a t h o l o g y  though t  to invo lve  bra in  
D A  dys func t ion .  
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